Physician

Matthew Pomykala, D.O.

According to 2025 Medicare claims, Matthew Pomykala, D.O. (NPI: 1548578594) practices ophthalmology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Orange, NY. This provider's primary affiliated billing organization is CRYSTAL RUN HEALTHCARE PHYSICIANS LLP (NPI: 1952376410; TIN: 133843560) and primary practice location at 10924-9998. Pomykala is affiliated with the CareMount Value Partners IPA (ACO ID: D0019), participating under the REACH model.

Pomykala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,174 traditional Medicare patients, billed 26,316 HCPCS/CPT codes, and received $2,537,555 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 404 prescription claims across 134 beneficiaries totaling $20,936 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $762,729 to $2,537,555. Similarly, Part D prescription costs have risen steadily, from $11,935 to $20,936. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.5M2015 Medicare payment: $762,729 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $428,536 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $527,433 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $790,291 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $879,506 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,063,291 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,314,779 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,519,118 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,786,784 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,537,555 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153544,386$762,729
20164112,722$428,536
20176645,236$527,433
20188545,615$790,291
20191,1455,822$879,506
20209986,180$1,063,291
20211,2037,741$1,314,779
20221,2478,310$1,519,118
20231,23114,754$1,786,784
20241,17426,316$2,537,555

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$51K$101K2015 Drug cost: $11,935 (USD; Tot_Drug_Cst)2016 Drug cost: $8,161 (USD; Tot_Drug_Cst)2017 Drug cost: $8,708 (USD; Tot_Drug_Cst)2018 Drug cost: $20,145 (USD; Tot_Drug_Cst)2019 Drug cost: $31,884 (USD; Tot_Drug_Cst)2020 Drug cost: $25,717 (USD; Tot_Drug_Cst)2021 Drug cost: $32,581 (USD; Tot_Drug_Cst)2022 Drug cost: $28,318 (USD; Tot_Drug_Cst)2023 Drug cost: $101,203 (USD; Tot_Drug_Cst)2024 Drug cost: $20,936 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201550120$11,935
201647128$8,161
201772170$8,708
2018116303$20,145
2019155390$31,884
2020165366$25,717
2021178455$32,581
2022149359$28,318
2023141359$101,203
2024134404$20,936

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2501,121$107
92014Established patient complete exam of visual system8671,336$97
67028Injection of drug into eye2411,495$91
92134Imaging of retina9962,392$30
92250Photography of the retina242317$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1313,146$3,868
Ketorolac TromethamineKetorolac Tromethamine361,356$1,035
EplerenoneEplerenone13812$793
LatanoprostLatanoprost311,900$652
Dorzolamide HclDorzolamide Hcl341,677$544

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Matthew Pomykala, D.O.?

Tedicare shows public-source Medicare data for Matthew Pomykala, D.O. (NPI 1548578594), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Pomykala, D.O. have ACO affiliation data?

Matthew Pomykala, D.O. is shown with ACO affiliation data for CareMount Value Partners IPA (REACH, ACO ID D0019).

What billing organization is linked to Matthew Pomykala, D.O.?

Matthew Pomykala, D.O. is linked to CRYSTAL RUN HEALTHCARE PHYSICIANS LLP (billing NPI 1952376410) in the available physician profile data.

Does Matthew Pomykala, D.O. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.